Watson Pharmaceuticals Receives FDA Approval For Levonorgestrel And Ethinyl Estradiol Tablets USP, 0.1mg / 0.02mg

Fri, 02 Jun 2006 11:00 AM EST

... WatsonPharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceuticalcompany, announced today that it has received final approval from theUnited States (U.S.) Food and Drug Administration (FDA) on its AbbreviatedNew Drug Application for levonorgestrel and ethinyl estradiol tablets USP,0.1mg / 0. [click link for full article] ...